94 related articles for article (PubMed ID: 17205058)
21. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-7R alpha mRNA expression increases as stem cells differentiate into T and B lymphocyte progenitors.
Orlic D; Girard LJ; Lee D; Anderson SM; Puck JM; Bodine DM
Exp Hematol; 1997 Mar; 25(3):217-22. PubMed ID: 9091297
[TBL] [Abstract][Full Text] [Related]
23. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF.
Estrov Z; Talpaz M; Ku S; Harris D; LaPushin R; Koller CA; Hirsh-Ginsberg C; Huh Y; Yee G; Kurzrock R
Leukemia; 1996 Sep; 10(9):1534-43. PubMed ID: 8751477
[TBL] [Abstract][Full Text] [Related]
24. The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.
ter Meulen CG; Jacobs CW; Wetzels JF; Klasen IS; Hilbrands LB; Hoitsma AJ
Transplantation; 2004 Jan; 77(2):281-6. PubMed ID: 14742994
[TBL] [Abstract][Full Text] [Related]
25. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
26. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
28. A granulocytic population with rearranged immunogenotype in chronic myelocytic leukemia blast crisis and Philadelphia-chromosome-positive acute leukemia with cross-lineage nature.
Kita K; Shimizu N; Miwa H; Ikeda T; Nishii K; Morita N; Uchida T; Shirakawa S; Tsutani H; Nasu K
Leukemia; 1993 Feb; 7(2):251-7. PubMed ID: 8381195
[TBL] [Abstract][Full Text] [Related]
29. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
30. The structure of interleukin-2 complexed with its alpha receptor.
Rickert M; Wang X; Boulanger MJ; Goriatcheva N; Garcia KC
Science; 2005 Jun; 308(5727):1477-80. PubMed ID: 15933202
[TBL] [Abstract][Full Text] [Related]
31. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
33. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
Korte A; Köchling J; Badiali L; Eckert C; Andreae J; Geilen W; Kebelmann-Betzing C; Taube T; Wu S; Henze G; Seeger K
Cytokine; 2000 Nov; 12(11):1597-608. PubMed ID: 11052810
[TBL] [Abstract][Full Text] [Related]
34. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
Wang X; Rickert M; Garcia KC
Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
[TBL] [Abstract][Full Text] [Related]
35. Clinical importance of interleukin-2 receptor alpha-chain expression in acute leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
Nakase K; Kita K; Kageyama S; Tsuji K; Miyanishi E; Miwa H; Tanaka I; Shirakawa S; Tanaka I; Anazawa H; Tsutani H; Kyo T; Dohy H; Kamada N; Doi S; Nasu K; Uchino H
Cancer Detect Prev; 1997; 21(3):273-9. PubMed ID: 9167045
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain.
Riccioni R; Rossini A; Calabrò L; Diverio D; Pasquini L; Lococo F; Peschle C; Testa U
Leuk Lymphoma; 2004 Aug; 45(8):1511-7. PubMed ID: 15370201
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells.
Nakase K; Kita K; Otsuji A; Anazawa H; Hoshino K; Sekine T; Shirakawa S; Tanaka I; Nasu K; Tsutani H
Br J Haematol; 1992 Mar; 80(3):317-26. PubMed ID: 1581211
[TBL] [Abstract][Full Text] [Related]
39. The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.
Lokau J; Petasch LM; Garbers C
Immunology; 2024 Mar; 171(3):377-387. PubMed ID: 38037265
[TBL] [Abstract][Full Text] [Related]
40. IL-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.
Nakase K; Kita K; Katayama N
Med Hypotheses; 2018 Jun; 115():5-7. PubMed ID: 29685196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
